| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |